AVS Announces Positive Safety and Effectiveness Data in First 95 Patients Treated in Pulse IVL IDE Study
Nov. 5, 2025 – Principal Investigator, Dr. Chris Metzger, Interventional Cardiologist at Ballad Health in…
Featured Press Releases
All News & Press Releases
AVS Granted Innovation Award at ISET
AVS received the 2025 Innovation Award at the International Symposium on Endovascular Therapy (ISET), a…
AVS Completes a $36M Series B Financing Ahead of IVL U.S. Commercial Launch
BOSTON–(BUSINESS WIRE)–Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating…
AVS Enrolls First Patient in U.S. Pivotal Intravascular Lithotripsy Study
BOSTON–(BUSINESS WIRE)–Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating…
AVS Partners with the Jacobs Institute to Expedite Clinical Trials for Coronary and Carotid Indications
BOSTON–(BUSINESS WIRE)–Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating…
AVS Brings New Approach to Lithotripsy: Vanguards of Health Care
In a Vanguards of Health Care podcast episode, AVS CEO, Mark Toland sits down with…
Pulse IVL with Angie Volk & Sean Gilligan of AVS
Angie Volk, VP of Business Development at AVS, and Sean Gilligan, COO at AVS, recently…
AVS Receives IDE Approval from FDA for Pivotal Intravascular Lithotripsy Study
BOSTON–(BUSINESS WIRE)–Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating…
AVS Appoints Elizabeth Galle as Vice President of Clinical Affairs
BOSTON–(BUSINESS WIRE)–AVS (Amplitude Vascular Systems, Inc), an early-stage medical device company focused on safely and…
Let’s Talk.
Looking to learn more about the development program for the innovative Pulse IVL™ or about AVS?
Reach Out Today